SARIN ARADHANA 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
SARIN ARADHANA
EVP, CFO
Transactions
- Award
Common Stock, par value $.0001 per share
[F1]2020-12-16+15,371→ 48,830 total - Tax Payment
Common Stock, par value $.0001 per share
[F2]2020-12-16$157.96/sh−6,853$1,082,500→ 41,977 total - Tax Payment
Common Stock, par value $.0001 per share
[F3]2020-12-16$157.96/sh−2,510$396,480→ 39,467 total
Footnotes (3)
- [F1]Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan.
- [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
Signature
/s/ Douglas Barry, Attorney-in-Fact for Aradhana Sarin|2020-12-18